retatrutide triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide is a triple-agonist drug
Pay in 4 interest-free payments of $5.56 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


















:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)



![Handbook of Physical Constants [engel-33803] 3809](https://cdn.shopify.com/s/files/1/0903/8521/9915/files/1_20250517_163427_0000_866a2cbb-0aec-4d97-9427-54d1a44f5cfd.png?v=1784945633)



